AdvertisementFDA Approves Marketing Of Consumer Genetic Tests For Some ConditionsApril 07, 2017Jessica BoddyfacebookEmail23andMe is now allowed to market tests that assess genetic risks for 10 health conditions, including Parkinson's and late-onset Alzheimer's diseases. (Meredith Rizzo/NPR)
